Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

Share Price is delayed by 15 minutes
Get Live Data
4,719.00    2.00 (0.04%)
Bid:
4,718.00
Ask:
4,719.00
Spread: 1.00 (0.021%)
Market Cap: £101.92b
BATS Live PriceLast checked at - London Stock Exchange

Intraday British American Tobacco Share Chart

Board and Committee Changes

6 Feb 2024 07:00

RNS Number : 0508C
British American Tobacco PLC
06 February 2024
 

?February 2024

British American Tobacco p.l.c. (the 'Company')

Board and Committee Changes

The Company announces that Sue Farr and Dimitri Panayotopoulos will step down from the Board with effect from the conclusion of the Company's AGM on 24 April 2024 having served as Non-Executive Directors for nine years.

As a result of these departures, the Company announces changes to the role of Senior Independent Director and to the composition of the Audit and Remuneration Committees.

With effect from the conclusion of the Company's AGM on 24 April 2024:

- Holly Keller Koeppel will be appointed as Senior Independent Director, succeeding Sue Farr. Holly has been a Non-Executive Director of the Company since July 2017 and she is currently Chair of the Audit Committee and a member of the Nominations Committee.

 

- Darrell Thomas will be appointed as Chair of the Audit Committee, succeeding Holly Keller Koeppel, who will remain a member of the Audit Committee.

 

- Kandy Anand will be appointed as Chair of the Remuneration Committee, succeeding Dimitri Panayotopoulos.

Commenting of the changes, Luc Jobin, said: "I would like to thank both Sue and Dimitri for their extensive contribution to the Board over their tenures. I would also like to thank Holly for chairing the Audit Committee since 2019. I look forward to welcoming Holly, Darrell and Kandy to their new roles."

From the conclusion of the 2024 AGM, the memberships of the Company's Audit and Remuneration Committees will be:

Audit Committee

Remuneration Committee

Chair: Darrell Thomas

Chair: Kandy Anand

Holly Keller Koeppel

Murray S. Kessler

Karen Guerra

Serpil Timuray

Véronique Laury

 

The above proposals are subject to re-election of each of the Directors at the 2024 AGM.

This announcement is made in accordance with LR 9.6.11.

Enquiries:

British American Tobacco Press Media Centre

+44 (0) 20 7845 2888 (24 hours) | @BATplc

Investor Relations

Victoria Buxton: +44 (0)20 7845 2012

Amy Chamberlain: +44 (0)20 7845 1124

Yetunde Ibe: +44 (0)20 7845 1095

John Harney: +44 (0)20 7845 1263

Jane Henderson: +44 (0)20 7845 1117

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZGGZMKNGDZM
Date   Source Headline
2nd Mar 20261:50 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 202611:00 amRNSBAT to Present at CAGNY; Reaffirming FY26 Guidance
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20265:00 pmRNSDirector/PDMR Shareholding
17th Feb 202612:30 pmRNSDirector/PDMR Shareholding
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20266:00 pmRNSDirector/PDMR Shareholding
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20262:00 pmRNSAnnual Financial Report
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:30 amRNSShare Buyback Programme
12th Feb 20267:05 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSPreliminary Results
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20269:00 amRNSBoard Update - Chair Extension and SID Appointment
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20263:00 pmRNSHolding(s) in Company
9th Feb 202611:00 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 202611:10 amRNSDirector/PDMR Shareholding
6th Feb 202611:05 amRNSDirector/PDMR Shareholding
6th Feb 202611:00 amRNSDirector/PDMR Shareholding
6th Feb 202610:45 amRNSDirector/PDMR Shareholding
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 202612:15 pmRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20264:30 pmRNSHolding(s) in Company
26th Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.